![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 33, 29369-29376, August 16, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
, andFrom the Center for Cardiovascular Sciences, Albany Medical College, Albany, New York 12208
Received for publication, July 24, 2001, and in revised form, April 23, 2002
| |
ABSTRACT |
|---|
|
|
|---|
Fatty acyl-CoA synthetase (FACS, fatty acid:CoA
ligase, AMP forming; EC 6.2.1.3) plays a central role in intermediary
metabolism by catalyzing the formation of fatty acyl-CoA. In
Escherichia coli this enzyme, encoded by the
fadD gene, is required for the coupled import and
activation of exogenous long-chain fatty acids. The E. coli FACS (FadD) contains two sequence elements, which comprise
the ATP/AMP signature motif (213YTGGTTGVAKGA224
and 356GYGLTE361) placing it in the superfamily
of adenylate-forming enzymes. A series of site-directed mutations were
generated in the fadD gene within the ATP/AMP signature
motif site to evaluate the role of this conserved region to enzyme
function and to fatty acid transport. This approach revealed two major
classes of fadD mutants with depressed enzyme activity: 1)
those with 25-45% wild type activity
(fadDG216A, fadDT217A,
fadDG219A, and
fadDK222A) and 2) those with 10% or less
wild-type activity (fadDY213A,
fadDT214A, and
fadDE361A). Using anti-FadD sera, Western blots
demonstrated the different mutant forms of FadD that were present and
had localization patterns equivalent to the wild type. The defect in
the first class was attributed to a reduced catalytic efficiency
although several mutant forms also had a reduced affinity for ATP. The
mutations resulting in these biochemical phenotypes reduced or
essentially eliminated the transport of exogenous long-chain fatty
acids. These data support the hypothesis that the FACS FadD functions in the vectorial movement of exogenous fatty acids across the plasma
membrane by acting as a metabolic trap, which results in the formation
of acyl-CoA esters.
Fatty acyl-CoA synthetase
(FACS,1 fatty acid:CoA
ligase, AMP forming; EC 6.2.1.3) plays a central role in intermediary
metabolism by catalyzing the formation of fatty acyl-CoA. These
bioactive fatty acid metabolites are involved in protein transport (1, 2), enzyme activation (3, 4), protein acylation (5-7), cell signaling
(8-10), and transcriptional control (11-15) in addition to serving as
substrates for FACS catalyzes the formation of fatty acyl-CoA by a two-step process
that proceeds through the hydrolysis of ATP to yield pyrophosphate. One
of the key features of this catalysis is the formation of an adenylated
intermediate (21). This activation step involves the linking of the
carboxyl group of the fatty acid through an acyl bond to the phosphoryl
group of AMP. Subsequently a transfer of the fatty acyl group to the
sulfhydryl group of coenzyme A occurs releasing AMP. By analogy with
acetyl-CoA synthetase, it is likely this reaction precedes via a
Bi-Uni, Uni-Bi Ter-molecular ping-pong mechanism with fatty acid, ATP,
and CoA all serving as substrates (22, 23).
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-oxidation and phospholipid biosynthesis. In
Escherichia coli the FACS FadD is hypothesized to catalyze the activation of long-chain fatty acid to CoA thioesters concomitant with transport by a process termed vectorial esterification (16, 17).
The concerted activities of FadD and the outer membrane fatty acid
transport protein FadL essentially render the process of fatty acid
transport unidirectional. The seminal work of Overath and colleagues
(18) showed that FACS activity was found both within the membrane and
soluble fractions suggesting that this enzyme moves between the cytosol
and plasma membrane to facilitate the vectorial esterification of
exogenous fatty acids. Indeed, subsequent studies have suggested that
the enzyme is recruited to the plasma membrane, but no information has
been amassed on the underlying mechanism (19). The membrane association
of FadD may be similar to that of CTP:phosphocholine
cytidylyltransferase, an enzyme required for phospholipid biosynthesis
that is catalytically active in the membrane and inactive when soluble
(20).
(Eq. 1)
The formation of an enzyme-bound adenylated intermediate is a
common mechanism used by a number of enzymes to activate their substrates. Sequence comparisons of adenylate-forming enzymes have
identified two highly conserved sequence elements
(YTSGTTGXPKGV and GYGXTE) that comprise
the ATP/AMP signature motif (24). The first sequence is generally
125-130 residues upstream from the second. A third less-conserved
element that is thought to contribute to ATP/AMP binding overlaps the
FACS signature (70-75 residues downstream from the second), which we
have shown is involved in both catalysis and specificity of the fatty
acid substrate (25).
(Eq. 2)
The focus of the present work was to identify specific residues within
the ATP/AMP signature critical for function and to further investigate
the role of this enzyme in the process of long-chain fatty acid
transport. A series of alanine substitutions were generated in the
region of FadD corresponding to the ATP/AMP signature motif site.
Subsequent analyses of the mutant forms of the enzyme permitted
classification into three groups. Those with wild-type or nearly
wild-type levels of oleoyl-CoA synthetase activity, those with
oleoyl-CoA synthetase activities reduced 40-80% when compared with
wild-type, and those with essentially undetectable levels of oleoyl-CoA
synthetase activity. Several of the altered forms of the enzyme with
detectable oleoyl-CoA synthetase activity had reduced catalytic rates
as opposed to a reduction in affinity for ATP attesting to the
importance of this highly conserved region for catalysis. Substitutions
within the ATP/AMP signature motif of FadD, which resulted in depressed FACS activities also had depressed fatty acid transport levels. These
data support the notion the membrane-associated fatty acyl-CoA synthetase FadD plays a central role in the transmembrane movement and
metabolic activation of exogenous long-chain fatty acids in E. coli.
| |
EXPERIMENTAL PROCEDURES |
|---|
|
|
|---|
Bacterial Strains and Growth Conditions--
The bacterial
strains used in this study were: BMH 71-18 (thi supE
(lac proAB) mutS::Tn10
[F' proAB
lacIqZ
M15]), JM109
(endA1 relA1 gyrA96 thi
hsdR17 (rK
, mK+) relA
supE44 a
(lacproAB) [F' traD36
proAB lacIqZ
M15]),
LS6928 (fadR fadD88
zea::Tn10), LS1547 (prototrophic wild-type), LS1548 (
fadR), LS1908 (
fadR
fadD::Kanr), LS6952
(recBC), and BL21 (
DE3)/pLysS. Strain LS1908 was
constructed by replacing the coding region of fadD with the
kanamycin resistance gene cartridge (Kanr;
Amersham Biosciences) using a two-step process. First, the
coding region of fadD in pN300 (24) was deleted and replaced
by the Kanr cartridge thereby maintaining >500
bp of flanking DNA to generate pJW201. Second, this plasmid was
digested with BamHI to generate a linear DNA molecule,
transformed into strain LS6952 and movement of
fadD::Kanr by P1 transduction into
strain LS1548 to generate the
fadR
fadD::Kanr strain LS1908. The
fadD deletion in LS1908 was confirmed by PCR of chromosomal
DNA using primers specific to bacterial DNA flanking the deletion and
by a loss of acyl-CoA synthetase activity. Bacterial cultures were
grown at 37 °C in a gyratory shaker in Luria broth or tryptone broth
(TB). When minimal media was required, medium E supplemented
with vitamin B1 (EB1) was used (26). Carbon
sources, sterilized separately, were added to final concentrations of
25 mM glucose, 25 mM potassium acetate, 5 mM decanoate, or 5 mM oleate. When oleate or
decanoate were used as a carbon source, polyoxyethylene 20 cetyl ether
(Brij 58) was added to a final concentration of 0.5%. As required,
amino acids were added to a final concentration of 0.01%. When
required to maintain plasmids, antibiotics were added to 100 µg/ml
ampicillin, 40 µg/ml kanamycin, 10 µg/ml tetracycline, and 40 µg/ml chloramphenicol. Growth of bacterial cultures was routinely
monitored using a Klett-SummersonTM colorimeter equipped
with a blue filter.
Amino Acid Sequence Comparisons-- Protein sequence comparisons were performed using MultAlign version 5.3.3 (27) with sequences that were conserved among the fatty acyl-CoA synthetases or members of the adenylate forming superfamily. Sequence comparisons were directed against the SWIS-PROT data base using a 0.01 probability threshold with complexity filtering and blosum62 score table.
Site-directed Mutagenesis--
Site-directed mutations within
the fadD gene were generated using the Altered
SitesTM mutagenesis system from Promega as previously
described (28). Specific mutations were confirmed using
dideoxysequencing and fadD-specific oligonucleotides (24).
Once the mutation was confirmed, BamHI or
SacII-SalI fragments containing the different
fadD alleles were purified and ligated into pACYC177. The
designations of the final constructions are given in Table I. The
plasmid constructs were then transformed into the host strain LS1908
(
fadR
fadD::Kanr) for analysis.
His6FadD Overexpression and
Purification--
Strain BL21 (
DE3)(pLysS) was transformed with
plasmid pN3576 encoding the bacterial fatty acyl-CoA synthetase FadD
containing a hexameric histidine tag (25). The expression and
purification of His6FadD has been previously described
(25). Briefly, cells were induced with
isopropyl-1-thio-
-D-galactopyranoside (1 mM) for 90 min and the enzyme was purified from a clarified
cell extract using Ni2+-NTA-agarose affinity chromatography
(Qiagen). The His-tagged enzyme elutes as a single band between 250 and
300 mM imidazole. Antisera were prepared against purified
FadD using a commercial vendor (BioWorld, Dublin, OH). Selected
fadD alleles were subcloned as cassettes into pN3576 for
expression and purification of mutant forms of the enzyme as detailed
under "Results."
Western Blotting--
Western blotting of cell extracts from
wild-type and
fadD strains transformed with the plasmid
constructs harboring the different fadD alleles was
performed as previously described (30). Briefly total cellular protein
or isolated membrane and cytosolic fractions were subjected to
SDS-polyacrylamide gel electrophoresis and electrophoretically transferred onto nitrocellulose membranes (pore size, 0.45 µm) (Micron Separations Inc.). Following transfer to nitrocellulose, membranes were pretreated for 1 h at room temperature with gentle shaking in 5% powdered milk + 0.1% Tween 20 in Tris-buffered saline (TTBS; 20 mM Tris, 0.5 M NaCl, pH 7.5).
Following this blocking step, anti-FadD sera (1:25,000 dilution) was
added directly and incubated an additional hour. Membranes were washed
with TTBS three times and subsequently incubated with goat anti-rabbit
IgG horseradish peroxidase conjugate (1:7,500) in 5% powdered milk + TTBS for 1 h at room temperature. Membranes were washed in TTBS as
detailed above and developed using enhanced chemiluminescence (ECL;
Amersham Biosciences) or by the addition of the peroxidase substrate
tetramethylbenzidene as specified by the vendor (Promega).
The soluble and particulate fractions of cells containing the different fadD alleles were separated and probed for FadD and mutant forms of FadD using Western blots and anti-FadD sera. Briefly, cells were grown as detailed above and lysed using a French pressure cell at 12,000 p.s.i. The cell lysates were clarified to remove unbroken cells and the supernatants were subjected to ultracentrifugation (60,000 × g for 30 min; TLA-100 rotor) to separate the membrane (particulate) fraction from the cytosolic fraction. The membranes were resuspended and centrifugation repeated. The protein concentrations of the membrane and cytosolic fractions were adjusted to 8-10 µg/10 µl and analyzed by Western blots as detailed above. The distribution between the membrane and cytosolic fractions of the mutant forms of FadD were compared with those from wild-type FadD.
Measurement of Fatty Acyl-CoA Synthetase Activity-- FACS activity was monitored using a modification of a protocol defined by Kameda and Nunn (29). Cell extracts were prepared from wild-type fadD strains by sonication on ice as previously described (25). Cell extracts were added to reaction mixtures containing 200 mM Tris-HCl, pH 7.5, 2.5 mM ATP, 8 mM MgCl2, 2 mM EDTA, 20 mM NaF, 0.1% Triton X-100, 10 µM [3H]oleate, 0.5 mM coenzyme A and incubated 10 min at 37 °C. For the kinetic experiments the concentration of ATP was varied between 0.05 and 2.5 mM. Reactions were initiated by the addition of CoA and terminated by the addition of isopropyl alcohol, n-heptane, 1 M H2SO4 (40:10:1). The aqueous phase, containing acyl-CoA formed during the reaction, was extracted 3 times with 2.5 ml of n-heptane and subjected to scintillation counting.
Fatty Acid Transport-- Oleate transport was measured as previously described (30). Following growth to mid-log phase (5 × 108 cells/ml) in TB, cells were harvested, washed once with minimal media EB1, and resuspended in EB1 containing 0.5% Brij 58 and 200 µg/ml chloramphenicol. The cells were starved for an exogenous energy source with aeration for 30 min at 30 °C. Following this starvation period, 1 ml of cells was added to 1 ml of an assay mixture containing 200 µM [3H]oleate (potassium salt). At appropriate time points (t = 0, 2, and 4 min), duplicate aliquots (100 µl) were rapidly pipetted onto prewetted GN-6 filters (Gelman), washed twice with EB1 containing 0.5% Brij 58, air-dried, and counted. Results were expressed as picomole of oleate transported/min/mg of cell protein. For the kinetic experiments on selected fadD mutant alleles, the final concentration of oleate was varied (10-100 µM) in the reaction mixture. The values presented from the transport experiments represent the means (±S.E) from at least three independent experiments. All transport data were subjected to analysis of variance using StatView (Abacus Concepts, Inc.).
Other--
[3H]Oleic acid and
[
-35S]dATP were purchased from PerkinElmer Life
Sciences. [14C]Decanoate was obtained from Sigma. Enzymes
for routine DNA manipulations were obtained from Promega, Invitrogen,
or New England Biolabs. Antibiotics and other supplements for bacterial
growth were obtained from Difco and Sigma. All other chemicals were
obtained from standard suppliers and were of reagent grade.
| |
RESULTS |
|---|
|
|
|---|
Identification of an ATP/AMP-binding Signature Motif
within the Fatty Acyl-CoA Synthetase FadD--
One of the key features
of the catalytic mechanism of FACS is the formation of an adenylated
intermediate (21). This activation step involves the linking of the
carboxyl group of the fatty acid to the phosphoryl group of AMP and
subsequent transfer of the acyl chain to the acceptor molecule coenzyme
A. The formation of an enzyme-bound adenylated intermediate was a
common mechanism used by a number of enzymes to activate their
substrates. Sequence comparisons of enzymes, which share this catalytic
property, identified two highly conserved sequence elements that
comprise the ATP/AMP-binding signature motif (Fig.
1). Within the family of adenylate
forming enzymes there was a third sequence element of this signature
that was less well conserved and partially overlaps the FACS
signature motif (25). In the E. coli FACS FadD, the two
regions comprising the ATP/AMP signature have been identified on the
basis of sequence similarities as
213YTGGTTGVAKGA224 and
356GYGLTE361.
|
Construction of Site-directed Substitutions within the ATP/AMP-binding Signature of FACS-- The homologies noted above served to guide studies using site-directed mutagenesis to define whether this region of FACS was essential for enzyme activity. Based on data from other adenylate-forming enzymes, the two highly conserved sequence elements contribute to a region of the enzyme hypothesized to be required for ATP binding and catalysis. A number of specific amino acid residues within the ATP/AMP signature motif were substituted with alanine to assess their contribution to enzymatic activity (Fig. 1, Table I). Western blots using anti-FadD sera demonstrated the protein levels of wild-type FadD and the mutant forms of FadD were equivalent (Fig. 2). These data support the notion that the mutant forms of FadD were expressed at levels approximating the wild type and there was no indication the proteins had reduced stability compared with the wild type. FadD was found in both the soluble and particulate fractions of the bacterial cell (18, 29). Thus we monitored the levels of FadD and mutant forms of FadD in both the soluble and particulate fractions using Western blots and found no discernable changes in patterns indicating that amino acid substitutions within the ATP/AMP signature did not result in an enzyme with altered cellular localization (Table II). As the specific amino acids targeted for substitution were postulated to reside within the catalytic center of the enzyme, it seems likely that subtle conformational changes will result that cannot be detected using these methods. Whereas the anti-FadD sera was prepared using highly purified His6FadD, two additional proteins were recognized, which are likely to be other adenylate-forming enzymes that share epitopes in common with FadD (Fig. 2). One of these was likely to be the undefined open reading frame designated YDID, which encodes an acyl-CoA synthetase-like protein that was 30% identical to FadD. YDID does not, however, contribute long-chain acyl-CoA synthetase activity.2
|
|
|
Fatty Acyl-CoA Synthetase Activities of Whole Cell Extracts from
fadD Mutants Containing Substitutions within the Putative
ATP/AMP-binding Signature Motif--
This work was driven
by the hypothesis that the ATP/AMP signature sequence elements were
required for ATP binding and the formation of the adenylated
intermediate. FACS activities were monitored in whole cell extracts
using oleate (C18:1) and decanoate (C10:0) as
substrates in the
fadD strain LS1908 transformed with pN300 (wild-type fadD), the plasmid vector pACYC177 and
plasmids encoding the collection of fadD alleles (Table II).
The alleles fadDY213A,
fadDT214A, fadDG216A,
fadDT217A, fadDG219A, and
fadDK222A (within the first sequence element of
the signature) and fadDE361A (within the second
element) had markedly reduced enzymatic activities using oleate as the
fatty acid substrate. As with our previous studies describing the FACS
signature motif (25), the present studies also revealed two major
classes of mutants with depressed enzyme activity: 1) those with
25-45% wild type activity (fadDG216A,
fadDT217A, fadDG219A, and
fadDK222A) and 2) those with 10% or less
wild-type activity (fadDY213A,
fadDT214A, and fadDE361A)
(Table II). Given that these mutant forms of FadD were expressed at
wild-type levels and had the same localization patterns, these data
would argue that these residues were crucial for catalytic activity.
Determination of Vmax, Km, and kcat Values for Fatty Acyl-CoA Synthetase Activities from fadD Mutants as a Function of ATP Concentration-- The data presented above indicated that specific residues within the ATP/AMP signature were important for enzymatic activity. To investigate this further, kinetic studies were undertaken to specifically evaluate the role of ATP in catalysis (Table III, Fig. 3). We suspected that several of the fadD mutants with substitutions within the ATP/AMP signature would be defective for ATP binding and thus would have a significantly higher Km for ATP when compared with the wild-type enzyme. As shown in Fig. 3, the fadDY213A and fadDE361A alleles resulted in enzymes with no measurable activity over a range of ATP concentrations. FadDY213A may be defective in ATP binding as is the case for the comparable residue in the mammalian fatty acid transport protein FATP1, which also was a member of the adenylate-forming family of enzymes (31, 32). By comparison with the phenylalanine activating subunit (PheA) of gramicidin synthetase in Bacillus brevis, Glu361 was essential for the catalytic activity of the enzyme. The homologous amino acid in PheA was a glutamate, which appears to function in concert with a neighboring tyrosine to coordinate the binding of Mg2+-AMP (33). In this regard, Glu361 may specifically contribute to ATP binding.
|
|
Three different fadD alleles (fadDT214A, fadDG216A and fadDG219A) resulted in enzyme activities that had kcat values 2-15-fold lower than wild-type, whereas the Km values for ATP were relatively unchanged. This suggests that the primary role of these residues were for catalysis as opposed to ATP binding. Two other alleles (fadDT217A and fadDK222A) affected both Km and kcat. Both mutants had kcat values that were reduced nearly 4-fold and Km values that were increased when compared with the wild type. These results were consistent with the notion that these two residues contribute to ATP binding. On the basis of previous work on PheA, the positive charge on the comparable lysine residue was thought to function by directing ATP to the binding site (33).
Analysis of Long-chain Fatty Acid Transport--
In view of the
compromised acyl-CoA synthetase activities in the fadD
alleles described in the preceding sections, we postulated this would
lead to reduced levels of long-chain fatty acid import. Therefore, we
selected a subset of these fadD mutants and defined the
patterns of fatty acid transport using [3H]oleate as the
substrate as detailed under "Experimental Procedures." One of the
fadD alleles examined (fadDY213A) was
severely compromised by oleate transport when compared with the
wild type, two (fadDT217A and
fadDE361A) had activities that were reduced
considerably, but detectable, and one
(fadDG219A) resulted in fatty acid transport
levels that were only modestly reduced when compared with wild type
(Fig. 4). When fatty acid transport was
measured using different concentrations of oleate in a selected subset
of mutants (fadDY213A,
fadDT217A, and
fadDE361A), the same patterns of activity were
found (Fig. 5) indicating the changes in
transport rate were the direct result of changes in the catalytic
efficiency of FadD. Kinetic constants extracted from these experiments
indicated that the Km of oleate transport resulting
from FadDT217A was essentially equivalent to the wild type,
whereas FadDE361A resulted in a 3-fold reduction (Table
IV). The changes in
Vmax were more dramatic indicating that a
reduction in the catalytic activity of FadD resulted in a commensurate
reduction in oleate transport. The addition of exogenous ATP to the
fatty acid transport assay mixture had no effect on the measured fatty
acid transport rates of strains containing the wild-type FadD or mutant
forms of FadD (data not shown), which suggested that the intracellular pools of ATP were required and sufficient for enzymatic activity as
previously suggested (45). These data, in conjunction with those
presented above, argue that there was specific coupling between fatty
acid import and activation of exogenous long-chain fatty acids in
E. coli.
|
|
|
Lipid Activation of Fatty Acyl-CoA Synthetase-- The E. coli FACS FadD appears to be an essential component of the long-chain fatty acid transport apparatus, perhaps by acting to metabolically trap the fatty acid as a CoA thioester. A central question that remains to be answered is how this enzyme was specifically involved in this process. Indeed, there is increasing evidence that in higher eukaryotic systems, this enzyme also plays a role in long-chain fatty acid transport (46). The first studies on the subcellular localization of a long-chain FACS were carried out on mammalian small intestinal mucosa where the enzyme was predominantly localized in the microsomal fraction (34, 35). A mouse isoform of FACS was found within the plasma membrane and was thought to function in concert with a fatty acid transport protein (36). Previous work on FadD has shown that it was present in both the particulate and soluble fractions of the cell (18, 19, 29). These observations suggest that FadD may partition into the membrane during its catalytic cycle and suggests this enzyme functions to abstract fatty acids from the membrane concomitant with esterification with CoA.
FACS activity from E. coli was routinely monitored in the
presence of low concentrations of nonionic detergent. When detergent was removed, FACS activity either cannot be measured or was extremely low indicating that either the substrate requires delivery in a
micellar form and/or that FACS prefers a lipophilic environment for
activity. Total E. coli lipid can functionally replace the nonionic detergent in restoring enzyme activity (Fig.
6) implying that the enzyme requires a
lipophilic environment to be active. In this regard, FadD may indeed be
lipid activated as it associates with the membrane.
|
| |
DISCUSSION |
|---|
|
|
|---|
The present studies were initiated to identify residues within fatty acyl-CoA synthetase required for catalysis and the vectorial import of exogenous long-chain fatty acids. Protein sequence homology searches have identified a number of amino acid residues as active site candidates, and in particular, identified residues common to the more limited family of fatty acyl-CoA synthetases and to the larger family of ATP/AMP-binding proteins. Site-directed mutagenesis of the fadD gene was undertaken to specifically evaluate the contribution of amino acid residues identified in the region called the ATP/AMP signature motif in the E. coli FACS, FadD. The crystallographic structures of two members of the ATP/AMP-binding family (firefly luciferase and the phenylalanine activating subunit of gramicidin S synthetase (PheA)) have been solved and thus serve as a platform for discussions of conserved residues that may participate in ligand binding and enzyme catalysis (33, 37). The experimental data obtained using the site-directed fadD mutants detailed from this work and from our previous work (25) coupled with the predicted structure of FadD (38) provide a foundation of information required to more fully understand the role of this enzyme in the fatty acid activation/transport process.
The conservation of residues within the two sequence elements of the
ATP/AMP signature motif by all adenylate family members strongly
suggests that these regions contribute to the binding of ATP and/or to
the formation of the enzyme adenylated reaction intermediate, because
ATP is the one substrate common to all members. The crystal structure
of firefly luciferase reveals that the N-terminal domain comprises the
major portion of the molecule and consists of a distorted antiparallel
-barrel and two
-sheets, which were flanked on either side by
-helices. Based on the predicted three-dimensional model of FadD
from E. coli, the majority of these residues are clustered
in a cleft separating two domains of the enzyme (38). In addition, the
FACS signature sequence motif is predicted to lie in the same cleft
providing compelling evidence that the ATP/AMP and FACS signature
sequences contribute to the catalytic core of the enzyme (25, 38).
The first sequence element of the ATP/AMP signature motif is the most
highly conserved sequence of amino acids in the superfamily of
adenylate-forming enzymes (39, 40). Although this sequence (YTSG(ST)TGXPKGV) has poor homology to the Walker A type
motif (GXXXXGK(TS)), it is rich in glycine and contains a
lysine. The Walker A motif forms a phosphate-binding loop found in a
large number of nucleotide-binding proteins (41). The lysyl residue in
this motif is thought to be responsible for binding the
-phosphate of the nucleoside triphosphate. A comparable Lys has been identified in
the ATP-binding site of SecA, a protein involved in protein transport
across the plasma membrane of E. coli (42). In B. brevis the comparable Lys is critical for ATP-PPi exchange in the
nonribosomal peptide synthetase tyrocidine synthetase I (43). Substitution of this homologous residue to methionine in
4-chlorobenzoate:CoA ligase results in a nearly 3-fold increase in the
Km for ATP and a 4-fold drop in catalytic activity
indicating the importance of this residue in ATP binding (44). In the
present work, steady state kinetic results from whole cells expressing the fadDK222A allele demonstrated a 3-fold
increase in Km for ATP and a 4-fold decrease in
catalysis, which supports the hypothesis that Lys222 of the
E. coli FACS was involved in ATP binding. The predicted three-dimensional model of FadD places Lys222 in a
disordered loop connecting two antiparallel
-strands that faces the
cleft hypothesized to represent the catalytic core of the enzyme
(38).
Other potential key residues within this loop that may contribute to
ATP binding were Tyr213 and Thr214. The data
presented here suggests that both Tyr213 and
Thr214 were important for the catalytic competence of the
enzyme. Whereas nearly 70% of the members of the adenylate-forming
family of enzymes contain a Tyr at the position comparable with
Tyr213 in FadD, this work was the first to document a
potentially important role for this residue in catalytic activity. We
suggest that Tyr213 contributes to the catalytic integrity
of the enzyme as the mutant form FadDT312A was devoid of
any enzymatic activity even though it was expressed at wild type levels
and had comparable localization patterns. The homologous tyrosine
(Tyr189) in PheA of gramicidin S synthetase does not form
specific contacts with AMP, perhaps indicative of a role in catalysis
(33). On the other hand, there is considerable evidence, which supports the role of the adjacent Thr214 in nucleotide binding. In
the crystal structure of PheA, Thr190 (corresponding to
Thr214 in E. coli) lies adjacent to
Tyr189 and contacts the
-phosphate of AMP. Our data show
that Thr214 in the E. coli FadD is critical for
function. This interpretation suggests that this residue may form
contacts with AMP to stabilize the fatty acyl-AMP intermediate.
The crystal structure of PheA complexed with AMP shows a Mg2+ bridge between the invariant glutamate of the second sequence element of the ATP/AMP signature (corresponding to Glu361 of FACS) and the O-1 phosphate of AMP. Substitution of this glutamate to alanine in FadD results in complete loss of enzyme activity that results in an inability to transport long-chain fatty acids. The predicted three-dimensional structure for FACS, which we have generated, suggests that this glutamate lies in proximity to Thr213 and Tyr214, which is presumed to be involved in nucleotide binding (33).
An additional goal in the present work was to provide evidence linking
the catalytic activity of FadD to long-chain fatty acid transport.
Overath and colleagues (18) first showed that FadD was partially
membrane associated and required for the conversion of exogenous
long-chain fatty acids to CoA thioesters thereby rendering fatty acid
transport unidirectional. This enzyme is clearly required for fatty
acid import and activation in E. coli as revealed in the
present studies showing that the import of [3H]oleate is
abolished in a
fadD strain. Additionally, specific mutations corresponding to the ATP/AMP signature motif that reduced or
abolished enzyme activity likewise reduced or abolished the import of
exogenous long-chain fatty acids. Indeed, these data fully support
Overaths hypothesis that vectorial acylation is one underlying
biochemical mechanism that governs fatty acid transport.
We have previously shown that the long-chain fatty acid transport system in E. coli: 1) is partially shock sensitive, 2) requires ATP generated by either substrate-level or oxidative phosphorylation, and 3) requires the proton electrochemical gradient across the inner membrane for maximal proficiency (45). More specifically, the transport of oleate requires ATP generated through the substrate level or oxidative phosphorylation, which reflects the ATP requirement of FadD as a component of this transport apparatus. In addition, these previous studies demonstrate that the process of long-chain fatty acid transport is linked to the proton electrochemical gradient across the inner membrane. In other words, the long-chain fatty acid transport system of E. coli requires both intracellular pools of ATP and an energized inner membrane.
Fig. 7 shows a model of how we
hypothesize FadD functions in the vectorial transport of exogenous
fatty acids. FadD is found both within the particulate and soluble
fractions of the cell (18, 19, 29). There is evidence that the enzyme
is recruited to the membrane although the signal that promotes this
association remains elusive (19). We have shown that an energized
plasma membrane is necessary for optimal fatty acid transport and have suggested that uncharged fatty acids simply flip across the inner membrane by diffusion and are then abstracted from the membrane by FadD
(45). It is temping to speculate that FadD specifically associates with
the membrane in response to exogenous protonated long-chain fatty acids
in the membrane. In the present work, we show that the mutant forms of
FadD containing substitutions within the ATP/AMP signature motif are
expressed at levels equivalent to the wild type and are found within
both the particulate and soluble fractions of the cell. These data
argue that there must be regions of FadD outside the catalytic core,
which are responsible for membrane association. In addition, whereas
the signal that promotes membrane association is undefined, it seems
plausible that an increase in free fatty acid concentration within the
inner membrane was sufficient to promote the association of ATP-bound FadD to the membrane. The formation of the fatty acyl adenylate effectively pulls the free fatty acids from the membrane for subsequent thioesterification to coenzyme A. The net result is the metabolic trapping of fatty acyl-CoA within the cell rendering the process unidirectional. Upon release of fatty acyl-CoA, the enzyme becomes ATP-bound and the cycle repeats.
|
The present work has established a platform of information, which
serves for our current investigations toward understanding the
mechanism and specificity of substrate and cofactor binding of this
enzyme further. Clearly, this line of investigation is essential to
understand the mechanisms that underpin the general role of fatty
acyl-CoA synthetases and the particular role of the E. coli
FadD in the coupled import and activation of exogenous long-chain fatty acids.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Linda Wolff and Karen Ostberg for technical assistance with Western blots and fatty acid transport assays.
| |
FOOTNOTES |
|---|
* This work was supported in part by National Science Foundation Grant MCB-9816414 (to P. N. B.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Supported by a Research Experience for Undergraduates supplement
from the National Science Foundation.
§ To whom correspondence should be addressed: Center for Cardiovascular Sciences, The Albany Medical College, 47 New Scotland Ave., MC-8 Albany, NY 12208. Tel.: 518-262-6416; Fax: 518-262-8101; E-mail: blackp@mail.amc.edu.
Published, JBC Papers in Press, May 28, 2002, DOI 10.1074/jbc.M107022200
2 P. Black and C. Gallati, unpublished data.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: FACS, fatty acyl-CoA synthetase; TB, tryptone broth; EB1, medium E supplemented with vitamin B1; TTBS, Tween 20 in Tris-buffered saline.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Glick, B. S., and Rothman, J. E. (1987) Nature 326, 309-312[CrossRef][Medline] [Order article via Infotrieve] |
| 2. |
Pfanner, N.,
Glick, B. S.,
Arden, S. R.,
and Rothman, J. E.
(1990)
J. Cell Biol.
110,
955-961 |
| 3. | Lai, J. C., Liang, B. B., Jarvi, E. J., Cooper, A. J., and Lu, D. R. (1993) Res. Commun. Chem. Pathol. Pharmacol. 82, 331-338[Medline] [Order article via Infotrieve] |
| 4. | Bronfman, M., Orellana, A., Morales, M. N., Bieri, F., Waechter, F., Staubli, W., and Bentley, P. (1989) Biochem. Biophys. Res. Commun. 159, 1026-1031[CrossRef][Medline] [Order article via Infotrieve] |
| 5. | McLaughlin, S., and Aderem, A. (1995) Trends Biochem. Sci. 20, 272-276[CrossRef][Medline] [Order article via Infotrieve] |
| 6. |
Gordon, J. I.,
Duronio, R. J.,
Rudnick, D. A.,
Adams, S. P.,
and Gokel, G. W.
(1991)
J. Biol. Chem.
266,
8647-8650 |
| 7. |
Li, Z. N.,
Hongo, S.,
Sugawara, K.,
Sugahara, K.,
Tsuchiya, E.,
Matsuzaki, Y.,
and Nakamura, K.
(2001)
J. Gen. Virol.
82,
1085-1093 |
| 8. |
Korchak, H. M.,
Kane, L. H.,
Rossi, M. W.,
and Corkey, B. E.
(1994)
J. Biol. Chem.
269,
30281-30287 |
| 9. | Murakami, K., Ide, T., Nakazawa, T., Okazaki, T., Mochizuki, T., and Kadowaki, T. (2001) Biochem. J. 353, 231-238[CrossRef][Medline] [Order article via Infotrieve] |
| 10. | Faergeman, N. J., and Knudsen, J. (1997) Biochem. J. 323, 1-12[Medline] [Order article via Infotrieve] |
| 11. |
DiRusso, C. C.,
Heimert, T. L.,
and Metzger, A. K.
(1992)
J. Biol. Chem.
267,
8685-8691 |
| 12. | DiRusso, C. C., Metzger, A. K., and Heimert, T. L. (1993) Mol. Microbiol. 7, 311-322[Medline] [Order article via Infotrieve] |
| 13. | Hertz, R., Magenheim, J., Berman, I., and Bar-Tana, J. (1998) Nature 392, 512-516[CrossRef][Medline] [Order article via Infotrieve] |
| 14. | van Aalten, D. M., DiRusso, C. C., and Knudsen, J. (2001) EMBO J. 20, 2041-2050[CrossRef][Medline] [Order article via Infotrieve] |
| 15. | van Aalten, D. M., DiRusso, C. C., Knudsen, J., and Wierenga, R. K. (2000) EMBO J. 19, 5167-5177[CrossRef][Medline] [Order article via Infotrieve] |
| 16. | Black, P. N., Faergeman, N. J., and DiRusso, C. (2000) J. Nutr. 130, 305S-309S[Medline] [Order article via Infotrieve] |
| 17. | DiRusso, C. C., Black, P. N., and Weimar, J. D. (1999) Prog. Lipid Res. 38, 129-197[CrossRef][Medline] [Order article via Infotrieve] |
| 18. | Overath, P., Pauli, G., and Schairer, H. U. (1969) Eur. J. Biochem. 7, 559-574[Medline] [Order article via Infotrieve] |
| 19. | Mangroo, D., and Gerber, G. E. (1993) Biochem. Cell Biol. 71, 51-56[Medline] [Order article via Infotrieve] |
| 20. |
Watkins, J. D.,
and Kent, C.
(1992)
J. Biol. Chem.
267,
5686-5692 |
| 21. | Groot, P. H., Scholte, H. R., and Hulsmann, W. C. (1976) Adv. Lipid Res. 14, 75-126[Medline] [Order article via Infotrieve] |
| 22. | Cleland, W. W. (1963) Biochim. Biophys. Acta 67, 104-137[Medline] [Order article via Infotrieve] |
| 23. | Cleland, W. W. (1963) Biochim. Biophys. Acta 67, 173-187[Medline] [Order article via Infotrieve] |
| 24. |
Black, P. N.,
DiRusso, C. C.,
Metzger, A. K.,
and Heimert, T. L.
(1992)
J. Biol. Chem.
267,
25513-25520 |
| 25. |
Black, P. N.,
Zhang, Q.,
Weimar, J. D.,
and DiRusso, C. C.
(1997)
J. Biol. Chem.
272,
4896-4903 |
| 26. | Miller, J. H. (1972) Experiments in Molecular Genetics , Cold Spring Harbor Laboratory, Cold Spring Harbor, NY |
| 27. |
Corpet, F.
(1988)
Nucleic Acids Res.
16,
10881-10890 |
| 28. | Black, P. N., and Zhang, Q. (1995) Biochem. J. 310, 389-394[Medline] [Order article via Infotrieve] |
| 29. |
Kameda, K.,
and Nunn, W. D.
(1981)
J. Biol. Chem.
256,
5702-5707 |
| 30. |
Kumar, G. B.,
and Black, P. N.
(1993)
J. Biol. Chem.
268,
15469-15476 |
| 31. |
Stuhlsatz-Krouper, S. M.,
Bennett, N. E.,
and Schaffer, J. E.
(1998)
J. Biol. Chem.
273,
28642-28650 |
| 32. | Stuhlsatz-Krouper, S. M., Bennett, N. E., and Schaffer, J. E. (1999) Prostaglandins Leukot. Essent. Fatty Acids 60, 285-289[CrossRef][Medline] [Order article via Infotrieve] |
| 33. | Conti, E., Stachelhaus, T., Marahiel, M. A., and Brick, P. (1997) EMBO J. 16, 4174-4183[CrossRef][Medline] [Order article via Infotrieve] |
| 34. |
Sleeman, M. W.,
Donegan, N. P.,
Heller-Harrison, R.,
Lane, W. S.,
and Czech, M. P.
(1998)
J. Biol. Chem.
273,
3132-3135 |
| 35. | Marra, C. A., and de Alaniz, M. J. (1999) Lipids 34, 343-354[CrossRef][Medline] [Order article via Infotrieve] |
| 36. |
Gargiulo, C. E.,
Stuhlsatz-Krouper, S. M.,
and Schaffer, J. E.
(1999)
J. Lipid Res.
40,
881-892 |
| 37. | Conti, E., Franks, N. P., and Brick, P. (1996) Structure 4, 287-298[Medline] [Order article via Infotrieve] |
| 38. |
Black, P. N.,
DiRusso, C. C.,
Sherin, D.,
MacColl, R.,
Knudsen, J.,
and Weimar, J. D.
(2000)
J. Biol. Chem.
275,
38547-38553 |
| 39. | Dieckmann, R., Lee, Y. O., van Liempt, H., von Dohren, H., and Kleinkauf, H. (1995) FEBS Lett. 357, 212-216[CrossRef][Medline] [Order article via Infotrieve] |
| 40. | Chang, K. H., and Dunaway-Mariano, D. (1996) Biochemistry 35, 13478-13484[CrossRef][Medline] [Order article via Infotrieve] |
| 41. | Serrano, R., Kielland-Brandt, M. C., and Fink, G. R. (1986) Nature 319, 689-693[CrossRef][Medline] [Order article via Infotrieve] |
| 42. |
Klose, M.,
Storiko, A.,
Stierhof, Y. D.,
Hindennach, I.,
Mutschler, B.,
and Henning, U.
(1993)
J. Biol. Chem.
268,
25664-25670 |
| 43. |
Gocht, M.,
and Marahiel, M. A.
(1994)
J. Bacteriol.
176,
2654-2662 |
| 44. | Chang, K. H., Xiang, H., and Dunaway-Mariano, D. (1997) Biochemistry 36, 15650-15659[CrossRef][Medline] [Order article via Infotrieve] |
| 45. | Azizan, A., Sherin, D., DiRusso, C. C., and Black, P. N. (1999) Arch. Biochem. Biophys. 365, 299-306[CrossRef][Medline] [Order article via Infotrieve] |
| 46. |
Færgeman, N. J.,
Black, P. N.,
Zhou, X.,
Knudsen, J.,
and DiRusso, C. C.
(2001)
J. Biol. Chem.
276,
37051-37057 |
This article has been cited by other articles:
![]() |
E. Soupene and F. A. Kuypers Mammalian Long-Chain Acyl-CoA Synthetases Experimental Biology and Medicine, May 1, 2008; 233(5): 507 - 521. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Kienow, K. Schneider, M. Bartsch, H.-P. Stuible, H. Weng, O. Miersch, C. Wasternack, and E. Kombrink Jasmonates meet fatty acids: functional analysis of a new acyl-coenzyme A synthetase family from Arabidopsis thaliana J. Exp. Bot., February 10, 2008; (2008) erm325v1. [Abstract] [Full Text] [PDF] |